首页> 外文OA文献 >A novel dual-functioning ruthenium(II)–arene complex of an anti-microbial ciprofloxacin derivative — anti-proliferative and anti-microbial activity
【2h】

A novel dual-functioning ruthenium(II)–arene complex of an anti-microbial ciprofloxacin derivative — anti-proliferative and anti-microbial activity

机译:抗菌环丙沙星衍生物的新型双功能钌(II)-芳烃配合物—抗增殖和抗菌活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

7-(4-(Decanoyl)piperazin-1-yl)-ciprofloxacin, CipA, (1) which is an analogue of the antibiotic ciprofloxacin, and its ruthenium(II) complex [Ru(η6-p-cymene)(CipA-H)Cl], (2) have been synthesised and the x-ray crystal structures of 1·1.3H2O·0.6CH3OH and 2·CH3OH·0.5H2O determined. The complex adopts a typical pseudo-octahedral ‘piano-stool’ geometry, with Ru(II) π-bonded to the p-cymene ring and σ-bonded to a chloride and two oxygen atoms of the chelated fluoroquinolone ligand. The complex is highly cytotoxic in the low μM range and is as potent as the clinical drug cisplatin against the human cancer cell lines A2780, A549, HCT116, and PC3. It is also highly cytotoxic against cisplatin- and oxaliplatin-resistant cell lines suggesting a different mechanism of action. The complex also retained low μM cytotoxicity against the human colon cancer cell line HCT116p53 in which the tumour suppressor p53 had been knocked out, suggesting that the potent anti-proliferative properties associated with this complex are independent of the status of p53 (in contrast to cisplatin). The complex also retained moderate anti-bacterial activity in two Escherichia coli, a laboratory strain and a clinical isolate resistant to first, second and third generation β-lactam antibiotics.\ud\ud
机译:7-(4-(癸酰基)哌嗪-1-基)-环丙沙星,CipA,(1)是环丙沙星抗生素及其类似物的钌(II)络合物[Ru(η6-p-cymene)(CipA- H)Cl],(2)已经合成,并且确定了1·1.3H2O·0.6CH3OH和2·CH3OH·0.5H2O的x射线晶体结构。该络合物采用典型的伪八面体“钢琴凳”几何形状,其中Ru(II)π键合到对苯二甲基环上,而σ键合到氯化物和螯合的氟喹诺酮配体的两个氧原子上。该复合物在低μM范围内具有高度的细胞毒性,并且对人癌细胞A2780,A549,HCT116和PC3的疗效与临床药物顺铂一样强。它对顺铂和奥沙利铂耐药的细胞系也具有很高的细胞毒性,表明其作用机制不同。该复合物还对敲除肿瘤抑制物p53的人结肠癌细胞系HCT116p53保持低μM细胞毒性,表明与该复合物相关的有效抗增殖特性与p53的状态无关(与顺铂相反) )。该复合物还对两种大肠杆菌,实验室菌株和对第一,第二和第三代β-内酰胺类抗生素具有耐药性的临床分离株保留了中等的抗菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号